Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

Jaspreet Toor; Emily R. Adams; Maryam Aliee; Benjamin Amoah; Roy M. Anderson; Diepreye Ayabina; Robin Bailey; Maria Gloria Basáñez; David J. Blok; Seth Blumberg; Anna Borlase; Rocio Caja Rivera; Mariá Soledad Castaño; Nakul Chitnis; Luc E. Coffeng; Ronald E. Crump; Aatreyee Das; Christopher N. Davis; Emma L. Davis; Michael S. Deiner; Peter J. Diggle; Claudio Fronterre; Federica Giardina; Emanuele Giorgi; Matthew Graham; Jonathan I.D. Hamley; Ching I. Huang; Klodeta Kura; Thomas M. Lietman; Tim C.D. Lucas; Veronica Malizia; Graham F. Medley; Aronrag Meeyai; Edwin Michael; Travis C. Porco; Joaquin M. Prada; Kat S. Rock; Epke A. Le Rutte; Morgan E. Smith; Simon E.F. Spencer; Wilma A. Stolk; Panayiota Touloupou; Andreia Vasconcelos; Carolin Vegvari; Sake J. De Vlas; Martin Walker; T. Déirdre Hollingsworth

doi:10.1093/cid/ciaa933

Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

Jaspreet Toor, Emily R. Adams, Maryam Aliee, Benjamin Amoah, Roy M. Anderson, Diepreye Ayabina, Robin Bailey, Maria Gloria Basáñez, David J. Blok, Seth Blumberg, Anna Borlase, Rocio Caja Rivera, Mariá Soledad Castaño, Nakul Chitnis, Luc E. Coffeng, Ronald E. Crump, Aatreyee Das, Christopher N. Davis, Emma L. Davis, Michael S. DeinerPeter J. Diggle, Claudio Fronterre, Federica Giardina, Emanuele Giorgi, Matthew Graham, Jonathan I.D. Hamley, Ching I. Huang, Klodeta Kura, Thomas M. Lietman, Tim C.D. Lucas, Veronica Malizia, Graham F. Medley, Aronrag Meeyai, Edwin Michael, Travis C. Porco, Joaquin M. Prada, Kat S. Rock, Epke A. Le Rutte, Morgan E. Smith, Simon E.F. Spencer, Wilma A. Stolk, Panayiota Touloupou, Andreia Vasconcelos, Carolin Vegvari, Sake J. De Vlas, Martin Walker, T. Déirdre Hollingsworth^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

57 Citations (Scopus)

23 Downloads (Pure)

Abstract

Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.

Original language	English
Pages (from-to)	1463-1466
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	72
Issue number	8
DOIs	https://doi.org/10.1093/cid/ciaa933
Publication status	Published - 15 Apr 2021

Bibliographical note

Financial support. The NTD Modelling Consortium was supported by the Bill and Melinda Gates Foundation (grant number OPP1184344). S. B. acknowledges National Institutes of Health (NIH) grant R01 EY025350. L. E. C. acknowledges funding from the Dutch Research Council (NWO) (grant number 016.Veni.178.023). R. E. C., C. H., and K. S. R. acknowledge funding by the Bill and Melinda Gates Foundation through the Human African Trypanosomiasis Modelling and Economic Predictions for Policy (HAT MEPP) project (grant number OPP1177824). F. G. acknowledges funding from a European Marie Skłodowska-Curie fellowship (H2020-COFUND-2015-FP-707404). M. G. B. and J. I. D. H. acknowledge joint center funding for MRC GIDA (MRC Centre for Global Infectious Disease Analysis) (grant number MR/R015600/1) by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 program supported by the European Union. T. M. L. acknowledges funding from the NIH. E. M. acknowledges partial funding from the NIH (grant number RO1AI123245). T. C. receives salary from grants from the US NIH and from the Bill and Melinda Gates Foundation.

Publisher Copyright: © 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciaa933

ciaa933Licence: CC BY

Cite this

Toor, J., Adams, E. R., Aliee, M., Amoah, B., Anderson, R. M., Ayabina, D., Bailey, R., Basáñez, M. G., Blok, D. J., Blumberg, S., Borlase, A., Rivera, R. C., Castaño, M. S., Chitnis, N., Coffeng, L. E., Crump, R. E., Das, A., Davis, C. N., Davis, E. L., ... Hollingsworth, T. D. (2021). Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation. Clinical Infectious Diseases, 72(8), 1463-1466. https://doi.org/10.1093/cid/ciaa933

@article{aff7678849504b87bb4c6db0fb0a87bb,

title = "Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation",

abstract = "Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.",

author = "Jaspreet Toor and Adams, {Emily R.} and Maryam Aliee and Benjamin Amoah and Anderson, {Roy M.} and Diepreye Ayabina and Robin Bailey and Bas{\'a}{\~n}ez, {Maria Gloria} and Blok, {David J.} and Seth Blumberg and Anna Borlase and Rivera, {Rocio Caja} and Casta{\~n}o, {Mari{\'a} Soledad} and Nakul Chitnis and Coffeng, {Luc E.} and Crump, {Ronald E.} and Aatreyee Das and Davis, {Christopher N.} and Davis, {Emma L.} and Deiner, {Michael S.} and Diggle, {Peter J.} and Claudio Fronterre and Federica Giardina and Emanuele Giorgi and Matthew Graham and Hamley, {Jonathan I.D.} and Huang, {Ching I.} and Klodeta Kura and Lietman, {Thomas M.} and Lucas, {Tim C.D.} and Veronica Malizia and Medley, {Graham F.} and Aronrag Meeyai and Edwin Michael and Porco, {Travis C.} and Prada, {Joaquin M.} and Rock, {Kat S.} and {Le Rutte}, {Epke A.} and Smith, {Morgan E.} and Spencer, {Simon E.F.} and Stolk, {Wilma A.} and Panayiota Touloupou and Andreia Vasconcelos and Carolin Vegvari and {De Vlas}, {Sake J.} and Martin Walker and Hollingsworth, {T. D{\'e}irdre}",

note = "Financial support. The NTD Modelling Consortium was supported by the Bill and Melinda Gates Foundation (grant number OPP1184344). S. B. acknowledges National Institutes of Health (NIH) grant R01 EY025350. L. E. C. acknowledges funding from the Dutch Research Council (NWO) (grant number 016.Veni.178.023). R. E. C., C. H., and K. S. R. acknowledge funding by the Bill and Melinda Gates Foundation through the Human African Trypanosomiasis Modelling and Economic Predictions for Policy (HAT MEPP) project (grant number OPP1177824). F. G. acknowledges funding from a European Marie Sk{\l}odowska-Curie fellowship (H2020-COFUND-2015-FP-707404). M. G. B. and J. I. D. H. acknowledge joint center funding for MRC GIDA (MRC Centre for Global Infectious Disease Analysis) (grant number MR/R015600/1) by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 program supported by the European Union. T. M. L. acknowledges funding from the NIH. E. M. acknowledges partial funding from the NIH (grant number RO1AI123245). T. C. receives salary from grants from the US NIH and from the Bill and Melinda Gates Foundation. Publisher Copyright: {\textcopyright} 2020",

year = "2021",

month = apr,

day = "15",

doi = "10.1093/cid/ciaa933",

language = "English",

volume = "72",

pages = "1463--1466",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "8",

}

Toor, J, Adams, ER, Aliee, M, Amoah, B, Anderson, RM, Ayabina, D, Bailey, R, Basáñez, MG, Blok, DJ, Blumberg, S, Borlase, A, Rivera, RC, Castaño, MS, Chitnis, N, Coffeng, LE, Crump, RE, Das, A, Davis, CN, Davis, EL, Deiner, MS, Diggle, PJ, Fronterre, C, Giardina, F, Giorgi, E, Graham, M, Hamley, JID, Huang, CI, Kura, K, Lietman, TM, Lucas, TCD, Malizia, V, Medley, GF, Meeyai, A, Michael, E, Porco, TC, Prada, JM, Rock, KS, Le Rutte, EA, Smith, ME, Spencer, SEF, Stolk, WA, Touloupou, P, Vasconcelos, A, Vegvari, C, De Vlas, SJ, Walker, M & Hollingsworth, TD 2021, 'Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation', Clinical Infectious Diseases, vol. 72, no. 8, pp. 1463-1466. https://doi.org/10.1093/cid/ciaa933

TY - JOUR

T1 - Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

AU - Toor, Jaspreet

AU - Adams, Emily R.

AU - Aliee, Maryam

AU - Amoah, Benjamin

AU - Anderson, Roy M.

AU - Ayabina, Diepreye

AU - Bailey, Robin

AU - Basáñez, Maria Gloria

AU - Blok, David J.

AU - Blumberg, Seth

AU - Borlase, Anna

AU - Rivera, Rocio Caja

AU - Castaño, Mariá Soledad

AU - Chitnis, Nakul

AU - Coffeng, Luc E.

AU - Crump, Ronald E.

AU - Das, Aatreyee

AU - Davis, Christopher N.

AU - Davis, Emma L.

AU - Deiner, Michael S.

AU - Diggle, Peter J.

AU - Fronterre, Claudio

AU - Giardina, Federica

AU - Giorgi, Emanuele

AU - Graham, Matthew

AU - Hamley, Jonathan I.D.

AU - Huang, Ching I.

AU - Kura, Klodeta

AU - Lietman, Thomas M.

AU - Lucas, Tim C.D.

AU - Malizia, Veronica

AU - Medley, Graham F.

AU - Meeyai, Aronrag

AU - Michael, Edwin

AU - Porco, Travis C.

AU - Prada, Joaquin M.

AU - Rock, Kat S.

AU - Le Rutte, Epke A.

AU - Smith, Morgan E.

AU - Spencer, Simon E.F.

AU - Stolk, Wilma A.

AU - Touloupou, Panayiota

AU - Vasconcelos, Andreia

AU - Vegvari, Carolin

AU - De Vlas, Sake J.

AU - Walker, Martin

AU - Hollingsworth, T. Déirdre

N1 - Financial support. The NTD Modelling Consortium was supported by the Bill and Melinda Gates Foundation (grant number OPP1184344). S. B. acknowledges National Institutes of Health (NIH) grant R01 EY025350. L. E. C. acknowledges funding from the Dutch Research Council (NWO) (grant number 016.Veni.178.023). R. E. C., C. H., and K. S. R. acknowledge funding by the Bill and Melinda Gates Foundation through the Human African Trypanosomiasis Modelling and Economic Predictions for Policy (HAT MEPP) project (grant number OPP1177824). F. G. acknowledges funding from a European Marie Skłodowska-Curie fellowship (H2020-COFUND-2015-FP-707404). M. G. B. and J. I. D. H. acknowledge joint center funding for MRC GIDA (MRC Centre for Global Infectious Disease Analysis) (grant number MR/R015600/1) by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 program supported by the European Union. T. M. L. acknowledges funding from the NIH. E. M. acknowledges partial funding from the NIH (grant number RO1AI123245). T. C. receives salary from grants from the US NIH and from the Bill and Melinda Gates Foundation. Publisher Copyright: © 2020

PY - 2021/4/15

Y1 - 2021/4/15

N2 - Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.

AB - Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.

UR - http://www.scopus.com/inward/record.url?scp=85098735477&partnerID=8YFLogxK

U2 - 10.1093/cid/ciaa933

DO - 10.1093/cid/ciaa933

M3 - Article

C2 - 32984870

AN - SCOPUS:85098735477

SN - 1058-4838

VL - 72

SP - 1463

EP - 1466

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 8

ER -

Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this